Medical ProductsCompany
Hikma Pharmaceuticals M&A Summary
Hikma Pharmaceuticals has acquired 10 companies, including 2 in the last 5 years. A total of 2 acquisitions came from private equity firms.
Hikma Pharmaceuticals’ largest acquisition to date was in 2021, when it acquired Custopharm for $375M. Hikma Pharmaceuticals has acquired in 4 different US states, and 5 countries. The Company’s most targeted sectors include medical products (50%) and life science (40%).
Hikma Pharmaceuticals Business Overview
Where is Hikma Pharmaceuticals headquartered?
Hikma Pharmaceuticals is headquartered in London, United Kingdom.
What is Hikma Pharmaceuticals’ revenue?
Hikma Pharmaceuticals disclosed revenue of 2,517M USD for 2022 and 2,553M USD for 2021.
How many employees does Hikma Pharmaceuticals have?
Hikma Pharmaceuticals has 8,800 employees.
What sector is Hikma Pharmaceuticals in?
Hikma Pharmaceuticals is a medical products company.
When was Hikma Pharmaceuticals founded?
Hikma Pharmaceuticals was founded in 1978.
M&A Summary
-
M&A Total Activity10
- M&A Buy Activity10
- Total Sectors Invested 3
- Total Countries Invested 5
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
